Ocrelizumab extended dosing in Primary Progressive Multiple Sclerosis during the COVID-19 pandemic: a multicenter experience

E. D'Amico, C. Avolio,G. Lus,S. Bonavita,D. Ferraro, G. Callari,S. Barone, F. Patti,F. Granella, A. Zanghi

MULTIPLE SCLEROSIS JOURNAL(2022)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要